XRTX

XORTX Therapeutics Inc. XRTX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode XRTX NCEL WINT VRAX NKGN DRMA ELAB ATXI MLEC GTBP
6M -31.26 % -89.21 % -92.98 % -50.91 % -80.00 % 216.66 % -68.65 % 118.21 % -95.18 % -75.18 %
YTD -48.72 % -88.07 % -99.76 % -82.36 % -92.76 % 53.96 % -96.28 % -66.22 % -96.03 % -74.26 %
1Y -46.43 % -86.87 % -99.75 % -79.70 % -92.22 % 73.98 % -96.47 % -63.78 % -95.94 % -73.06 %
3Y -90.87 % -99.48 % -100.00 % -93.22 % -99.12 % -94.99 % -99.99 % -99.34 % -96.55 % -97.75 %
5Y -97.88 % -99.78 % -100.00 % -99.79 % -99.12 % -99.83 % -99.99 % -99.99 % -96.68 % -99.70 %
10Y -97.88 % -99.78 % -100.00 % -99.79 % -99.12 % -99.83 % -99.99 % -99.99 % -96.68 % -100.00 %
From the beginning -97.88 % -99.78 % -100.00 % -99.79 % -99.12 % -99.83 % -99.99 % -99.99 % -96.68 % -100.00 %

Dividend

XORTX Therapeutics Inc.